MDM2 — master regulator of the p53 tumor suppressor protein

THE UBIQUITIN SYSTEM

Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840

WAF1, a potential mediator of p53 tumor suppression

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063

Participation of p53 protein in the cellular response to DNA damage.

Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113

MDM2: RING Finger Protein and Regulator of p53

Wu, L., & Maki, C. G. (2005) · Springer eBooks · doi:10.1007/0-387-27421-9_34 · Cited by 4

Synchronization in stressp53 network

Devi, G. R., Alam, M. J., & Singh, R. K. B. (2015) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqv002 · Cited by 4

EJSO educational Special issue from the TARPSWG - Standard medical treatment and new options in retroperitoneal sarcoma

Kasper, B., Baldi, G. G., Loong, H. H.-F., & Trent, J. C. (2021) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2021.12.465 · Cited by 4

Structural Aspects of Organic Compounds as Proteasome Inhibitors Addressed to Several Diseases

Gomes, S. Q., Silva, G. M., Barcelos, M. P., Hage-Melim, L. I. D. S., & da Silva, C. H. T. D. P. (2022) · Engineering materials · doi:10.1007/978-3-031-07622-0_22 · Cited by 4

Systems biology approach deciphering the biochemical signaling pathway and pharmacokinetic study of PI3K/mTOR/p53-Mdm2 module involved in neoplastic transformation

Arora, D., & Singh, A. (2017) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-017-0162-9 · Cited by 4

Development and structural characterisation of human scFv targeting MDM2 spliced variant MDM215kDa

Lim, C. C., Chan, S. K., Lim, Y. Y., Ishikawa, Y., Choong, Y. S., Nagaoka, Y., & Lim, T. S. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.04.016 · Cited by 4

A single nucleotide polymorphism in the Mdm2 promoter and risk of sepsis

Kleiman, D. A., Calvano, J. E., Coyle, S. M., Macor, M., Calvano, S. E., & Lowry, S. F. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.12.049 · Cited by 4

Pharmacogenomics of the p53 tumor suppressor and its role in cancer chemoresistance

Liu, S., Bishop, W. R., Dasmahapatra, B., & Wang, Y. (2004) · Drug Development Research · doi:10.1002/ddr.10362 · Cited by 4

THYMOQUINONE: THE EVALUATION OF ITS CYTOTOXIC POTENTIAL, EFFECTS ON P53 STATUS AND THE CELL CYCLE IN VARIOUS CANCER CELL LINES

Mokashi, A. A. (2004) · UKnowledge (University of Kentucky) · Cited by 4

A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins

Ganesan, I. P., & Kiyokawa, H. (2025) · Cancers · doi:10.3390/cancers17040626 · Cited by 3

p53 and cancer metabolism

ZHANG, X.-H., & Le, L. I. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2022-0009 · Cited by 3

Alteration of pulmonary mitochondrial oxidation status, inflammation, energy metabolizing enzymes, oncogenic and apoptotic markers in mice model of diisononyl phthalate-induced asthma

Kehinde, S. A., Olajide, A. T., Akinpelu, O. J., & Ogunsanya, S. T. (2023) · Life Sciences Medicine and Biomedicine · doi:10.28916/lsmb.7.1.2023.113 · Cited by 3

Conformational Stability of the N-Terminal Region of MDM2

Rizzuti, B., Abián, O., Velázquez‐Campoy, A., & Neira, J. L. (2023) · Molecules · doi:10.3390/molecules28227578 · Cited by 3

Unlocking the Gateway: The Spatio-Temporal Dynamics of the p53 Family Driven by the Nuclear Pores and Its Implication for the Therapeutic Approach in Cancer

Ikliptikawati, D. K., Makiyama, K., Hazawa, M., & Wong, R. W.-C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137465 · Cited by 3

Generation and characterization of transgenic mice expressing a T‐cell receptor specific for the tumour‐associated antigen MDM2

Xue, S., Bendle, G. M., Holler, A., & Stauss, H. J. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02793.x · Cited by 3

A rare case of atypical/anaplastic meningioma with MDM2 amplification

Wylleman, R., Dêbiec‐Rychter, M., & Sciot, R. (2018) · Rare Tumors · doi:10.1177/2036361318779511 · Cited by 3

Microarray and ChIP-seq data analysis revealed changes in p53-mediated transcriptional regulation in Nutlin-3-treated U2OS cells

Zhao, S., NIU, F., Xu, C., Ye, L., Bi, G.-B., Chen, L., Gong, P., TIAN, G., & Nie, T.-H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3933 · Cited by 3

VEGF and p53 Biomarkers in Pediatric Patients With Langerhans Cell Histiocytosis

Mehrazma, M., Mahjoob, F., Rafsanjani, K. A., Jafari, D., Farahani, S. J., & Harahdashti, A. L. (2013) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31828e51ae · Cited by 3

Targeting the MDM2–p53 Protein–Protein Interaction

Hardcastle, I. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00013-9 · Cited by 3

Characterization of the E3 Ubiquitin Ligase Pirh2

Tai, E. (2010) · TSpace (University of Toronto) · Cited by 3

Discovery of Furopyrimidine‐Pyrazole Hybrid Compounds Targeting p53‐MDM2 Interaction as Anticancer Agents

Mansour, M. A., Hassan, G. S., Jaballah, M. Y., Serya, R. A. T., Dege, N., Şahın, O., Sharaky, M. M., Zhang, X., Su, R., De, K., et al. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70085 · Cited by 2

The pyrrolizidine alkaloid lasiocarpine impairs cell cycle progression in vitro

Hessel‐Pras, S., Beckschulte, M., Peters, A., Koellner, A., Rosskopp, B., Stahl, A., Templin, M. F., Sprenger, H., Böhmert, L., Kuepper, J.-H., et al. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04185-y · Cited by 2

Alvaradoin E: an update of its anticancer potential and mechanisms of action

Kitić, D., Miladinović, B., Randjelović, M., Fagoonee, S., Popa, D. G., Călina, D. C., & Sharifi‐Rad, J. (2024) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.23.03035-3 · Cited by 2

Inhibition of all-trans retinoic acid on MDM2 gene expression in astrocytoma cell line SHG-44

Zeng, Y., Yang, Z., Long, X., & You, C. (2008) · Neuroscience Bulletin · doi:10.1007/s12264-008-0716-z · Cited by 2

Gene Expression upon Proliferation and Differentiation of Hematopoietic Cells with PH Chromosome ex vivo

GRINEVA, N. I., Duchovenskay, E. A., Тимофеев, А. М., Akhlynina, T. V., Герасимова, Л. П., Манакова, Т. Е., Боровкова, Т. В., Шмаров, Д. А., Sarycheva, N. G., Naydenova, N. M., et al. (2012) · Acta Naturae · doi:10.32607/20758251-2012-4-3-95-114 · Cited by 2

Acupuncture and Moxibustion for Antiaging

Wu, H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3357-6_10 · Cited by 2

Suppression of the mouse double minute 4 gene causes changes in cell cycle control in a human mesothelial cell line responsive to ultraviolet radiation exposure

Bunderson‐Schelvan, M., Erbe, A. K., Schwanke, C. M., & Pershouse, M. A. (2009) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20498 · Cited by 2

El nucléolo como un regulador del envejecimiento celular

Rosete-Enríquez, M., Padrós, M. R., & Vindrola, O. (2007) · Medicina-buenos Aires · Cited by 2

MDM2 Molecular Imaging for the Prediction of Chemotherapeutic Sensitivity in Human Breast Cancer Xenograft

Fu, P., Sun, L., Cao, X., Li, L., & Zhao, C. (2014) · Molecular Imaging · doi:10.2310/7290.2014.00018 · Cited by 2

Targeted Inhibitor Design: Lessons from Small Molecule Drug Design, Directed Evolution, and Vaccine Research

Park, S., Mann, J. K., & Li, N. (2013) · Cited by 2

The p53-Mdm2 Loop: A Critical Juncture of Stress Response

Levav-Cohen, Y., Goldberg, Z., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_5 · Cited by 2

Sunlight Protection by Vitamin D Compounds

Mason, R. S., Rybchyn, M. S., & Dixon, K. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00110-3 · Cited by 2

p53 and RNA viruses: The tug of war

Pal, A., Tripathi, S. K., Rani, P., Rastogi, M., & Das, S. (2023) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1826 · Cited by 2

When Undergraduates Ask “Why,” Chemical Biology Answers

Kritzer, J. A. (2006) · ACS Chemical Biology · doi:10.1021/cb600319s · Cited by 2

Inhibition of Protein–Protein Interactions by Peptide Mimics

Becerril, J., Rodriguez, J. M., Wyrembak, P. N., & Hamilton, A. D. (2010) · Wiley eBooks · doi:10.1002/9780470972137.ch5 · Cited by 2

Identification of proteins that interact with DWNN domain of SNAMA a member of a novel protein superfamily

Rakgotho, P. M. (2008) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 2

The Strong Activation of p53 Tumor Suppressor Drives the Synthesis of the Enigmatic Isoform of DUSP13 Protein

Krześniak, M., Łasut-Szyszka, B., Będzińska, A., Gdowicz‐Kłosok, A., & Rusin, M. (2024) · Biomedicines · doi:10.3390/biomedicines12071449 · Cited by 1

Restoration of the Y220C p53 Full-Length Mutant by PK11000: a Molecular Dynamics Study of an Intrinsically Disordered Protein

Stetson, S., Mancía, F. C., & Thayer, K. M. (2025) · ACS Omega · doi:10.1021/acsomega.5c05639 · Cited by 3

MDM2 and MDMX Regulators of p53 Activity

Momand, J. A., Aspuria, P. J., & Furuta, S. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_7 · Cited by 1

mRNA expression of G(1)-phase cell cycle regulatory molecules in bladder cancer.

Pantazis, E., Soulitzis, N., Soufla, G., Karyotis, I., Delakas, D., & Spandidos, D. A. (2011) · PubMed · Cited by 1

The facile and visualizable identification of broad-spectrum inhibitors of MDM2/p53 using co-expressed protein complexes

Yang, Y., Dong, Z., Hu, H., Peng, J., Sheng, Y., Yang, T., Yuan, S., Li, Z., Yang, J., Wells, T., et al. (2019) · The Analyst · doi:10.1039/c9an00350a · Cited by 1

Probing Alterations in MDM2 Catalytic Core Structure Effect of Garcinia Mangostana Derivatives: Insight from Molecular Dynamics Simulations

habbash, A. I. E., Aljoundi, A., Elamin, G., & Soliman, M. E. S. (2022) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-022-01101-4 · Cited by 1

System Biology Approach to Study Cancer Related Pathways

Guo, Y., & Yang, X. (2012) · Springer eBooks · doi:10.1007/978-94-007-4819-4_2 · Cited by 1

Sunlight, skin cancer and vitamin D

Mason, R. S., & Dixon, K. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00043-4 · Cited by 1

Regulatory role of protein p53 in the functional activity of the central nervous system

Kotov, V. N., Kostyaeva, M. G., Ibadullaeva, S. S., Ganshin, I. B., Ходорович, О. С., Valiev, T. T., & Kartasheva, A. F. (2024) · Morphology · doi:10.17816/morph.629463 · Cited by 1

Research Progress on Small Molecule Inhibitors of MDM2-p53 Protein-protein Interaction

Hu, M. Y., Xu, C., Xu, M., He, S., & Liu, D. (2025) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206358340250121060830 · Cited by 1

Protection of Pifithrin-α and Melatonin against Doxorubicin-Induced Cardiotoxicity.

Liu, X. (2003) · Digital Commons - East Tennessee State University (East Tennessee State University) · Cited by 1

Regulation of Angiogenesis by Tumour Suppressor Pathways

Lefebvre, K. J., Assadian, S., El-Assaad, W., & Teodoro, J. G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3685-0_8 · Cited by 1

Cancer Gene Therapy with the p53 Tumor Suppressor Gene

Meng, R. D., & El‐Deiry, W. S. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50019-7 · Cited by 1

Protein-Protein Interactions (PPIs) as an Alternative to Targeting the ATP Binding Site of Kinase

Sarvagalla, S., & Coumar, M. S. (2016) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-5225-0362-0.ch010 · Cited by 1

Cell death induction in p53-Mdm2 network regulated by p300 and HDAC1 using pinning control

Suárez, O. J., Vega, C. J., Sanchez, E. N., & Santiago, A. E. G. (2019) · International Conference on Electrical Engineering, Computing Science and Automatic Control (CCE) · doi:10.1109/iceee.2019.8884509 · Cited by 1

Identifizierung und Charakterisierung einer Verankerungsdomäne auf dem Tumorsuppressorgen p53, welche für die Inaktivierung durch zytoplasmatische Retention verantwortlich ist

Tumorvirologie, A. F., & Klotzsche, O. (2005) · Cited by 1

Regulation of DNA Repair and Apoptosis by p53 and Its Impact on Alkylating Drug Resistance of Tumor Cells

Boldogh, I. R., Bhakat, K. K., Bocangel, D., Das, G. M., & MITRA, S. P. (2004) · doi:10.1007/978-1-59259-735-2_5 · Cited by 1

Antisense Oligonucleotides and siRNA as Specific Inhibitors of Gene Expression: Mechanisms of Action and Therapeutic Potential

Förster, Y., & Schwenzer, B. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-474-2_20 · Cited by 1

Understanding the Effects of Cancer-Associated Mutations in the Tumor Suppressor Protein p53: Structural Consequences of Mutations and Possible Ways of Rescuing Oncogenic Mutants

Joerger, A. C., Friedler, A., & Fersht, A. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_17 · Cited by 1

Targeting cell cycle checkpoints to specifically kill cancer

Burgess, A. (2004) · The University of Queensland · doi:10.14264/107006

Prognostic and Predictive Markers in Radiation Therapy: Focus on Prostate Cancer

Ritter, M. A. (2007) · Cancer treatment and research · doi:10.1007/978-0-387-36744-6_5

Tumor suppressor p53 and transcriptional changes in cellular stress responses to UV radiation

Latonen, L. (2003) · Työväentutkimus Vuosikirja

P53: LA HISTORIA SIN FINAL DE UN POLIFACÉTICO GUARDIÁN

Valencia, J. C. B., Giraldo, I. P., & Molina, E. C. (2009) · Biosalud

Evaluation of the primary mouse hepatocyte model for the prediction of genotoxicity

Mathijs, K. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20091209km

Apoptosis gene expression profiling in lens development

Geatrell, J. C. (2007) · ORCA Online Research @Cardiff (Cardiff University)

Structural and functional interrogation of Anterior Gradient-2

Gray, T. A. (2013) · ERA

Ubiquitin-specific Protease 7 Plays a Critical Role in Control of Lytic Infection and Cell Transformation by Human Adenovirus Type 5

Koyuncu, E. (2009)

To reactivate or not to reactivate : Control of KSHV lytic replication is essential for apoptosis in response to p53 restoration

Sarek, G. (2010) · Työväentutkimus Vuosikirja

Molecular genetic studies on Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia - with focus on prognostic markers

Willander, K. (2014) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-104951

Case Study: Inhibitors of the MDM2‐p53 Protein–Protein Interaction

Shangary, S. K., Bernard, D., & Wang, S. (2010) · Wiley eBooks · doi:10.1002/9780470972137.ch10

Avaliação da expressão das proteínasMDM2, P53, P21WAF1 e pAKT em carinoma adenóide cístico e adenocarcinoma de glândulas salivares

de Lima, M. D. D. M. (2006) · doi:10.11606/d.23.2006.tde-19032007-163218

Identification of human Vam6p as a novel cellular interactor for Merkel cell polyomavirus large T antigen

Liu, X. (2011) · D-Scholarship@Pitt (University of Pittsburgh)

Targeting of the Myc pathway as a novel approach for cancer therapy

Mo, H. (2006) · Figshare

A Functional Analysis of the RNA Polymerase II Large Subunit C-Terminal Domain

Chapman, R. D. (2003) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.1104

Identifizierung und Charakterisierung metastatischer Vorläuferzellen aus dem Knochenmark beim Prostatakarzinom

Polzer, B. M. (2006) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.6002

Ubikitin-Proteozom Yolağının Karsinojenezdeki Rolü

Sümer-Turanlıgil, N. C., & Uyanıkgil, Y. (2010) · DergiPark (Istanbul University) · doi:10.17827/aktd.16057

Experimental brain tumors, dendritic cells and immunotherapy

Janelidze, S. (2008) · Lund University Publications (Lund University)

Hdm2 Small-Molecule Inhibitors For Therapeutic Intervention In B-Cell Lymphoma

Sosin, A. M. (2012) · Human Biology

Modifiers of expression in mutations of mismatch repair gene carriers in hereditary nonpolyposis colorectal cancer

Chen, J., Zhu, J., Pande, M., Amos, J., Frazier, M. L., & Wei, C. (2006) · Current Colorectal Cancer Reports · doi:10.1007/s11888-006-0020-0

Identification of tumor progression-related genes in astrocytoma cell lines

Zeng, Y., Yang, Z., You, C., & Han, Y. (2008) · Chinese Journal of Clinical Oncology · doi:10.1007/s11805-008-0391-x

The Role of Genomic Instabilities in Affecting Treatment Responses of Colorectal Cancer

Ricciardiello, L., & Bazzoli, F. (2002) · Digestive Diseases · doi:10.1159/000063158

Immunohistochemical Expression of MDM2 in Lung Carcinoma

(2002) · Handbook of immunohistochemistry and in situ hybridization of human carcinomas · doi:10.1016/s1874-5784(04)80023-0

Comment on: F. Sandra et al. “The role of MDM2 in the proliferative activity of ameloblastoma”, Oral Oncology 2002;38(2):153–57

O’Neill, I. D. (2002) · Oral Oncology · doi:10.1016/s1368-8375(02)00023-4

MOLECULAR PROFILING OF UROTHELIAL CARCINOMA

Lindgren, D. (2006) · Lund University Publications (Lund University)

Regulation of apoptosis during treatment and resistance development in tumour cells

Blomberg, J. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Efeito do hormônio tireoidiano (T3) sobre a expressão da E3 ligase Mdm2 e suas implicações na regulação do trofismo muscular.

Ramos, G. V. (2014) · doi:10.11606/t.42.2014.tde-19112014-154918

Human p53 and Hdm2: Cloning and Construction of Expression Plasmid

Nguyen, K. V. (2010) · Analytical Letters · doi:10.1080/00032710903327530

Identification of three novel regulatory pathways involved in the down-regulation of p63 protein levels

Accademico, A. (2010)

MARINA DE DEUS MOURA DE LIMA

Mdm, P. (2006)

Apoptosis and Cancer

O’Connor, S. L., Briones, F., Chari, N. S., Cho, S. H., Hamm, R. L., Kadowaki, Y., Lee, S., Spurgers, K. B., & McDonnell, T. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-361-3_12

Mutations in Non-MMR Genes Modifying or Mimicking Lynch Syndrome Phenotype

Pande, M., Chen, J., Wei, C., Huang, Y.-J., & Frazier, M. L. (2013) · Springer eBooks · doi:10.1007/978-94-007-6597-9_7

Switching Mechanism in the p53 Regulatory Network

Alam, M. J., Singh, V., & Singh, R. K. B. (2014) · Springer eBooks · doi:10.1007/978-94-017-9514-2_10

AVALIAÇÃO DA EXPRESSÃO DAS PROTEÍNAS p53, MDM2 E SUMO-1 EM LÍQUEN PLANO BUCAL, DISPLASIA EPITELIAL BUCAL E CARCINOMA DE CÉLULAS

Bucal, E. (2011)

The role of the transcription factor SRF in the inhibition of senescence in human and porcine smooth muscle cells

Konjer, N. (2009)

Induction of p53 Dependent Cellular Senescence Through HdmX Inhibition or YPEL3 Expression

Miller, K. L. (2010) · Journal of Bioresource Management

Preclinical Pharmacology of the MDM2 Antagonist Nutlin-3a

Zhang, F. (2011) · doi:10.21007/etd.cghs.2011.0372

Einfluss von Epothilon B und eines MDM2- Inhibitors auf das Zellüberleben und die Apoptose einer Kopf-Hals-Tumorzelllinie in Kombination mit Bestrahlung

München, L.-M.-U. (2012)

Estudio sobre funciones específicas de proteínas MAGE-I y su relevancia en oncología

de Toledo, M. F. P. (2015) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)

Changing the balance in apoptosis: key to enhance cisplatin sensitivity of testicular cancer

Koster, R. (2010) · University of Groningen research database (University of Groningen / Centre for Information Technology)

MicroRNAs and epigenetics in chemical carcinogenesis : an integrative toxicogenomics-based approach

Rieswijk, L. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160120lr

Specific requirements for translational regulation by a nascent peptide that stalls ribosomes in response to arginine

Spevak, C. C. (2006) · doi:10.6083/m4js9ncx

With or Without You: Studying the Requirement of p53 for Anti-Cancer Responses to Nuclear Export Inhibitors

Doak, A. E. (2016) · CU Scholar (University of Colorado Boulder)

Redox regulation of human P53 tumor suppressor gene activity: Identification of redox genes that play role in human P53 reporter gene activity

Ataç, B. (2008) · IYTE GCRIS Database (Izmir Institute of Technology)

MDM2 SNP309 polymorphism in Turkish population

Taş, A., Sarı, İ., Ağbektaş, T., & Siliğ, Y. (2017) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/223.v39i32356.369012

254 INVITED Small molecule inhibitors of the human MDM2-p53 interaction as anticancer agents

Wang, S., Shangary, S. K., Qin, Q., McEachern, D., Ding, K., Nikolovska‐Coleska, Z., Lu, Y., Malek, S. N., Guo, M., & Yang, D. (2008) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(08)72188-8

MDM2 and MDMX Regulators of p53 Activity

Momand, J. A., Aspuria, P. J., & Furuta, S. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_7 · Cited by 1

The regulation of MDM2 oncogene and its impact on human cancers

YuHan, Zhao, Haiyang, Yu, Wenwei, & Hu (2014) · 生物化学与生物物理学报：英文版 · Cited by 1

mdm-2 Inhibits the G1 Arrest and Apoptosis Functions of the p53 Tumor Suppressor Protein

Chen, J., Wu, X., Lin, J., & Levine, A. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2445 · Cited by 348

p76MDM2 Inhibits the Ability of p90MDM2to Destabilize p53

Perry, M. E., Mendrysa, S. M., Saucedo, L. J., Tannous, P., & Holubar, M. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5733 · Cited by 71